BioCorRx Inc. (BICX)
↓ Download CSV- Sector Services
- Fiscal year ends Dec 31
In fiscal 2025, BioCorRx Inc. reported revenue of $797.2K, up 10301.1% from the prior year. The company ran a net loss, with a net margin of -431.5%. It held $2.15M in total assets against $13.67M in total liabilities.
Key ratios (FY2025)
-606.0%
Operating margin
-431.5%
Net margin
+10301.1%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $797.2K | $7.7K | $89.2K | $213.8K | $48.3K | $122.6K | $240.3K | $376.7K | $657.3K | — |
| Cost of Revenue | — | $1.7K | $36.0K | $15.3K | $5.9K | $95.9K | $81.7K | $171.0K | $323.6K | $175.4K |
| Operating Income | -$4.83M | -$5.12M | -$3.79M | -$4.70M | -$5.51M | -$7.49M | -$5.56M | -$4.63M | -$2.89M | -$2.18M |
| Net Income | -$3.44M | -$5.11M | -$3.77M | -$4.38M | -$5.21M | -$3.51M | -$6.05M | -$6.58M | -$29.71M | -$5.90M |
| EPS (Diluted) | $-0.19 | $-0.49 | — | — | — | — | — | — | — | — |
| Total Assets | $2.15M | $385.9K | $388.9K | $766.6K | $820.0K | $1.83M | $3.93M | $628.2K | $338.9K | $470.4K |
| Total Liabilities | $13.67M | $12.74M | $10.34M | $8.97M | $7.78M | $6.04M | $4.99M | $6.33M | $4.23M | $8.60M |
| Shareholders' Equity | -$11.22M | -$12.12M | -$9.82M | -$8.08M | -$6.96M | -$4.21M | -$1.06M | -$5.71M | -$3.89M | -$8.13M |
| Cash & Equivalents | — | — | — | — | — | $592.1K | $2.65M | $279.8K | — | — |
| Operating Cash Flow | -$2.30M | -$1.10M | -$1.85M | -$2.04M | -$3.54M | -$2.15M | -$2.94M | -$1.83M | -$2.54M | -$2.00M |
| Capital Expenditures | — | — | — | $0 | $2.0K | $0 | — | $10.0K | — | $305.6K |
| Shares Outstanding | 24.49M | 13.30M | 8.67M | 7.72M | 6.70M | 5.46M | 5.33M | 2.60M | 2.44M | 181.80M |